Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
life sciences
medical device
national blog main
raleigh-durham blog main
san francisco blog main
san francisco top stories
2
×
acute migrane
bain capital
bausch health
breast cancer
clinical trials
deals
desmoid tumor
dihydroergotamine
dihydroergotamine mesylate
fda
food and drug administration
generic drug
glaxosmithkline
impel neuropharma
migraine
multiple myeloma
national organization for rare disorders
new york
new york blog main
new york top stories
nirogacestat
orbimed
pulmonary arterial hypertension
ra capital
raleigh-durham top stories
rare disease drugs
san francisco
satsuma pharmaceuticals
shin nippon biomedical laboratories
springworks therapeutics
startups
steadymed
tpg biotech
What
drug
2
×
firm
2
×
activity
biotech
building
companies
days
deal
developer
disease
dog
established
hasn’t
ipo
ipos
leading
line
lung
migraine
momentum
pah
pfizer
place
prep
rare
reaches
rivalry
satsuma
securing
seller
slowed
spinout
springworks
steadymed
stopped
summer
therapeutics
therapy
united
Language
unset
Current search:
firm
×
drug
×
" san francisco top stories "
×
@xconomy.com
4 years ago
Pfizer Spinout SpringWorks, Migraine Drug Firm Satsuma Prep IPOs
@xconomy.com
6 years ago
United Therapeutics Reaches $141M Deal for PAH Drug Firm SteadyMed
